rs2713579
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_032638.5(GATA2):c.*1758C>T variant causes a downstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.686 in 151,892 control chromosomes in the GnomAD database, including 36,046 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.69 ( 36046 hom., cov: 31)
Consequence
GATA2
NM_032638.5 downstream_gene
NM_032638.5 downstream_gene
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.591
Genes affected
GATA2 (HGNC:4171): (GATA binding protein 2) This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded protein plays an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 3-128479261-G-A is Benign according to our data. Variant chr3-128479261-G-A is described in ClinVar as [Benign]. Clinvar id is 2203427.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.75 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATA2 | NM_032638.5 | c.*1758C>T | downstream_gene_variant | ENST00000341105.7 | NP_116027.2 | |||
GATA2 | NM_001145661.2 | c.*1758C>T | downstream_gene_variant | NP_001139133.1 | ||||
GATA2 | NM_001145662.1 | c.*1758C>T | downstream_gene_variant | NP_001139134.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATA2 | ENST00000341105.7 | c.*1758C>T | downstream_gene_variant | 1 | NM_032638.5 | ENSP00000345681.2 | ||||
GATA2 | ENST00000487848.6 | c.*1758C>T | downstream_gene_variant | 1 | ENSP00000417074.1 | |||||
GATA2 | ENST00000696466.1 | c.*1758C>T | downstream_gene_variant | ENSP00000512647.1 | ||||||
GATA2 | ENST00000696672.1 | c.*1597C>T | downstream_gene_variant | ENSP00000512796.1 |
Frequencies
GnomAD3 genomes AF: 0.686 AC: 104111AN: 151774Hom.: 36004 Cov.: 31
GnomAD3 genomes
AF:
AC:
104111
AN:
151774
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.686 AC: 104212AN: 151892Hom.: 36046 Cov.: 31 AF XY: 0.683 AC XY: 50670AN XY: 74186
GnomAD4 genome
AF:
AC:
104212
AN:
151892
Hom.:
Cov.:
31
AF XY:
AC XY:
50670
AN XY:
74186
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Deafness-lymphedema-leukemia syndrome;C3280030:Monocytopenia with susceptibility to infections Benign:1
Feb 11, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at